Dr. LI Zhengwei graduated from Zhejiang University School of Medicine in 2014, and later obtained a doctor’s degree in internal medicine from the same institution. He completed standardized training for internal medicine residents, training for cardiovascular medicine subspecialty, and coronary intervention training in the Catheter Room of Cardiology at Sir Run Run Shaw Hospital. He is mainly engaged in clinical practice and research related to complex coronary heart disease intervention and green noninvasive intervention, cardiovascular imaging and function, and participated in a number of multi-center clinical randomized controlled trials, such as Neovas, Bioheart, maiquan, IBS iron-based absorbable stent clinical trials, and CT-FFR clinical trials, such as esFFR, ML-FFR, Artery FFR, etc. He presided over one project of Zhejiang medical and health science and technology plan and one project of Zhejiang traditional Chinese medicine science and technology plan, and participated in one general project funded by the National Natural Science Foundation, one provincial and ministerial project, and two projects supported by the Zhejiang Natural Science Foundation; He has published many high-quality and high-level academic papers as the first author.

Member of the Cardiovascular Randomized Controlled Trial Group of the Cardiovascular Branch of the Chinese Medical Association

Member of Oncocardiology Group of the Cardiovascular Branch of Zhejiang Medical Association